Explore the vast range of titles available.

DOI https://doi.org/10.70478/psicothema.2025.37.25Psicothema, 2025.Vol. 37 (nº 4). 16-28 PDFRevisión Selectiva de los Tratamientos Psicológicos Empíricamente Apoyados Para Problemas de Salud PediátricosSelective Review of Empirically Supported Psychological Treatments for Pediatric Health ProblemsIsabel Cuéllar-Flores1, Izaskun Basterra2, Silvia Cámara3, Borja Esteso-Orduña4, Deborah Fuentes-Casany5, Laura González-Riesco6, Amaia Izquierdo7, María del Pilar Mundo-Cid8, Estela Salcedo9, Raquel Seijas-Gómez10 & María Serrano-Villar111 Hospital Clínico San Carlos (Spain) 2 Hospital Universitario de Navarra (Spain) 3 Hospital General Universitario Gregorio Marañón (Spain) 4 Hospital Infantil Universitario Niño Jesús (Spain) 5 Institut d’Assistència Sanitària (Spain) 6 Hospital Sant Joan de Déu (Spain) 7 Hospital Río Hortega (Spain) 8 Hospital Universitari Germans Trias i Pujol (Spain) 9 Hospital Universitario Clínico San Cecilio (Spain) 10 Hospital Teresa Herrera (Spain) 11 Hospital de Getafe (Spain)ABSTRACT Background: Significant progress has been made in providing empirical support for psychological interventions designed to improve the health and behavior of children and young people with pediatric health problems. The objective of this study was to carry out a review of empirically supported psychological treatments for various health problems in the child and adolescent population. Method: Psychological treatments with empirical support for 12 pediatric health problems were reviewed based on the levels of evidence and how much they are recommended in the Spanish national health system Clinical Practice Guides. Results: Psychological treatments to address various health problems in the child and adolescent population have empirical support. The level of evidence ranges from low to high depending on the health problem. The review shows uneven deployment in different health problems. Conclusions: This review will help psychology professionals and healthcare managers to make decisions regarding psychological treatments for addressing pediatric health problems.RESUMEN Antecedentes: Se han logrado avances significativos en proporcionar apoyo empírico para intervenciones psicológicas diseñadas para mejorar la salud de niños/as y jóvenes que presentan problemas de salud pediátricos. El objetivo de este trabajo ha sido realizar una revisión de los tratamientos psicológicos empíricamente apoyados para el abordaje de diferentes problemas de salud en población infanto-juvenil. Método: Se han revisado los tratamientos psicológicos con apoyo empírico para 12 problemas de salud pediátricos en función de los niveles de evidencia y grados de recomendación de las Guías de Práctica Clínica del Sistema Nacional de Salud de España. Resultados: Los tratamientos psicológicos para el abordaje de varios problemas de salud en población infanto-juvenil cuentan con apoyo empírico. El nivel de evidencia oscila de bajo a alto en función del problema de salud. La revisión muestra un desarrollo desigual en los diferentes problemas de salud. Conclusiones: Esta revisión ayudará a los profesionales de la psicología y gestores en la toma de decisiones con respecto a los tratamientos psicológicos para el abordaje de los problemas de salud pediátricos.PDF English English

Obesity often develops in childhood. In children (6 to <12 years of age) with obesity, treatment with liraglutide for 56 weeks plus lifestyle interventions induced a greater mean change in BMI than lifestyle interventions alone.

IntroductionEmergency intracranial stenting in pediatric patients is a rare but potentially life-saving intervention in cases of severe neurovascular compromise unresponsive to medical treatment. While its use is well established in adults, pediatric data remain limited, particularly concerning safety, efficacy, and antiplatelet management in acute settings.Aim of StudyThis study presents a case series of six pediatric patients undergoing emergency intracranial stenting and proposes a practical, weight-based antiplatelet protocol to guide clinical management.MethodWe retrospectively reviewed six pediatric patients (ages 6–13) treated with emergency intracranial stenting at our institution between 2021 and 2024. Three patients received venous sinus stents for refractory pseudotumor cerebri. The remaining three underwent arterial stenting due to acute arterial dissection or focal arteriopathy with neurological deterioration despite maximal medical therapy and/or mechanical thrombectomy failure. All procedures were performed under general anesthesia by an experienced neurointerventional team. Pre-procedural imaging included MRI/MRV or CT/CTA. Antiplatelet therapy was tailored according to bleeding risk and imaging findings. Follow-up was conducted with an overall range of 3–36 months.Abstract A330 Figure 1[Image Omitted. See PDF.]ResultsAll six patients survived with good clinical outcomes. No major thrombotic or hemorrhagic complications occurred during the follow-up period.Abstract A330 Figure 2[Image Omitted. See PDF.]ConclusionEmergency intracranial stenting in carefully selected pediatric patients is feasible and may be life-saving. Based on our experience, a weight-based antiplatelet protocol appears safe and effective. Multicenter studies are needed to confirm these findings and support the development of standardized pediatric guidelines.Conflict of InterestNo

BackgroundThe Matsushima grading system is widely used to evaluate revascularization outcomes after Encephalo-Duro-Arterio-Synangiosis (EDAS) for Moyamoya vasculopathy by describing collateral ingrowth from the superficial temporal artery (STA) to the MCA territory. However, its subjective measurement and the potential ingrowth of collaterals to the ACA territory, as well as those from the MMA, are all limitations of the scale. The orbital grading system (OGS) is a new, objective scale initially developed to measure these outcomes in adults. We aim to evaluate this scale in the pediatric population.MethodsRetrospective analysis of patients with Moyamoya disease and syndrome treated with EDAS at a single major pediatric center from 2006–2023. An inter-rater reliability analysis was performed using 5 raters with different levels of training that provided scores for 30 blinded cases, and then a Fleiss’ kappa coefficient (k) was calculated as a measure of agreement beyond chance.Results101 patients with a mean age of 9 years old, mostly females (56.4%) and mostly comprised of Moyamoya disease (71.3%), were included. A total of 158 cerebral hemispheres were treated with EDAS (57 patients had bilateral surgeries). Most patients were categorized as Suzuki grade III or above (82.9%). At a median of 12.4 months, collateral growth graded using the Matsushima scale was A in 57.6%, B in 24%, C in 14.6%, and borderline grades in 3.8%. The OGS reported scores were grade 0 (7.0%), grade 1 (8.9%), grade 2 (43.7%), and grade 3 (40.5%). inter-rater agreement evaluation found that the OGS had a superior Kappa than the Matsushima Grading (0.51 vs. 0.15; p < 0.001).ConclusionThe OGS had higher inter-rater agreement rates compared to the Matsushima scale for identifying postoperative collateral ingrowth in children after EDAS. This scale offers a more objective way to evaluate radiological outcomes after EDAS for the pediatric population.DisclosuresA. Enriquez-Marulanda: None. M. Ruppert-Gomez: None. P. Lazatin: None. S. Staffa: None. S. Rangwala: None. D. Orbach: None. A. See: None. E. Smith: None. C. Ogilvy: None.